May 5, 2026 3-5pm ET
Tuesday on The Robert Scott Bell Show:
Hour 1
Health Freedom at the Forefront of Individual Rights vs. Government Debate Health freedom has emerged as a central issue in Arizona’s legislative session, with multiple bills advancing that seek to strengthen parental rights, limit government vaccine mandates, protect medical conscience, and restrict the influence of international health organizations such as the WHO, reflecting a broader national debate over individual medical autonomy versus public health authority. Lawmakers have introduced and advanced measures that would prohibit schools and state agencies from requiring vaccines without explicit parental consent, ban enforcement of federal or international vaccine mandates, and prevent medical professionals from facing disciplinary action for providing information or care that diverges from official recommendations. Proponents argue these bills are essential to prevent the kind of coercion seen during the COVID-19 pandemic and to affirm that parents, not the state, hold primary decision-making authority over their children’s health. Opponents, including some public health officials and medical organizations, contend that weakening vaccine requirements could lower immunization rates and increase risks of outbreaks for preventable diseases. The legislation aligns with similar efforts in other states and with the Make America Healthy Again movement’s emphasis on informed consent, transparency, and reduced pharmaceutical influence. Arizona’s actions are part of a growing state-level pushback against perceived federal and international overreach in health policy, with debates centering on the balance between collective public health goals and constitutional protections for bodily autonomy and parental rights. The outcome of these bills could significantly shape Arizona’s approach to future public health emergencies and set a precedent for other states navigating similar tensions.
Moderna to Inject 350 People With Experimental mRNA-1982 Lyme Disease Shot as Human Trials Expand Moderna is preparing to enroll approximately 350 healthy adults aged 18–70 in Canada in a Phase 2 randomized, placebo-controlled clinical trial for its experimental mRNA-1982 Lyme disease vaccine candidate, which encodes outer surface protein A (OspA) from Borrelia bacteria, as the company continues expanding mRNA technology into bacterial targets despite unresolved questions about toxicity, biodistribution, and potential shedding of vaccine-produced material via exosomes. The trial will evaluate safety, tolerability, and immunogenicity through initial dosing and booster phases, with monitoring for adverse events up to 21 months, and runs parallel to development of a heptavalent candidate mRNA-1975 targeting multiple Borrelia serotypes. The move follows Pfizer’s revival of a Lyme vaccine strategy previously withdrawn due to autoimmune concerns and lawsuits, and comes as FDA Commissioner Dr. Marty Makary has publicly linked Lyme disease origins to government lab research on Plum Island. Critics highlight that the trial record does not appear to address whether mRNA or OspA proteins can be packaged into extracellular vesicles and shed in bodily fluids, potentially transferring to others, raising informed consent issues. A 2023 Nature Reviews Drug Discovery paper co-authored by Moderna scientists acknowledges that avoiding “unacceptable toxicity” remains a major challenge for mRNA vaccines due to lipid nanoparticles, production methods, and tissue distribution. The article frames the trial as part of Moderna’s push to normalize mRNA platforms for common illnesses amid ongoing debates over long-term safety and the need for rigorous testing before broader deployment.
Profound Autism: New Definition by IACC Aims for Better Care and Research The Interagency Autism Coordinating Committee (IACC), significantly remade by Health Secretary Robert F. Kennedy Jr. with more activists and advocates aligned with his views, held its first meeting in 19 months and focused primarily on “profound autism,” voting to recommend a new federal research and policy designation for this subgroup that includes individuals with minimal or no speech, high support needs, and complex medical comorbidities, aiming to increase recognition, research funding, and services for a population often overlooked in mainstream autism efforts. Chair Sylvia Fogel emphasized the exhaustion faced by families providing lifelong care for minimally speaking autistic children with severe needs, while the committee recommended coordinated safety measures to prevent wandering and urged Medicaid to establish guidelines for diagnosis and associated health risks. The proposed definition of profound autism prioritizes functional limitations over strict IQ thresholds, differing from a 2022 Lancet article, and sparked debate among members about potentially excluding some individuals if drawn too narrowly. Federal members expressed concerns about the rushed process and procedural compliance with the Federal Advisory Committee Act after only days to review materials, with several abstaining from votes, while public members pushed forward. Critics, including former IACC members, argued the overhaul sidelined mainstream organizations and existing scientific literature on genetics and adult services in favor of diet, facilitated communication, and other areas. It remains unclear how much influence the committee’s recommendations will have on federal research priorities or policy given the controversy surrounding Kennedy’s changes.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
Today’s Homeopathic Hit is Cereus Bonplandii, a Night-blooming Cereus.
Boericke presents this remedy as acting strongly on the heart and chest, with characteristic convulsive, transfixing pains and sensations of weight and compression. It also includes neurological pain patterns extending through the head, chest, and extremities.
Download the Information Sheet
AI Outperforms Doctors in Diagnosing Patients, Harvard & Stanford Study Finds A collaborative study from Harvard Medical School and Stanford University has found that advanced AI systems, particularly large language models combined with multimodal data analysis, outperformed human physicians in diagnostic accuracy across a wide range of complex medical cases, achieving correct diagnoses in 85–90% of scenarios compared to 70–75% for doctors, highlighting the potential of artificial intelligence to reduce diagnostic errors that contribute to hundreds of thousands of patient harms annually in the United States. Researchers tested leading AI models against practicing physicians using anonymized real-world case studies that included symptoms, lab results, imaging, and patient history, finding that AI excelled particularly in rare or atypical presentations where human doctors were more prone to cognitive biases or anchoring on common conditions. The AI systems demonstrated stronger pattern recognition across specialties, better integration of conflicting data points, and more consistent application of up-to-date medical literature. However, the study also noted important limitations: AI performance dropped in cases with incomplete information or unusual patient demographics, lacked the nuanced clinical judgment and empathy of human doctors, and raised concerns about over-reliance potentially deskilling physicians or introducing new types of errors if models are trained on biased datasets. Experts emphasized that AI should serve as a supportive tool rather than a replacement, with hybrid models combining AI analysis and physician oversight showing the most promising results for improving accuracy while maintaining human accountability. The findings add to a growing body of research on AI in medicine and support calls for updated training programs, regulatory frameworks, and ethical guidelines to ensure safe integration into clinical practice.Hour 2
ACIP Attacked for Urging Shared Decision-Making The Advisory Committee on Immunization Practices (ACIP) is facing backlash after recommending a shift toward shared decision-making between physicians and patients for certain vaccines rather than maintaining strictly universal recommendations, a move that critics argue undermines longstanding public health strategies while supporters contend it reflects a more individualized and transparent approach to medical care. The change emphasizes that for some vaccines, particularly where risk may vary by individual circumstances, clinicians and patients should engage in informed discussions about benefits, risks, and personal factors rather than following blanket guidance, marking a departure from decades of uniform vaccination policy that prioritized population-level outcomes. Opponents, including major medical organizations and public health advocates, argue that weakening universal recommendations could reduce vaccination rates, create confusion among providers and families, and increase the risk of outbreaks of preventable diseases by eroding herd immunity, while also complicating insurance coverage and clinical workflows tied to standardized schedules. Supporters of the shift maintain that shared decision-making enhances patient autonomy, improves trust in healthcare providers, and allows for more nuanced application of medical evidence, particularly in cases where scientific consensus is evolving or where individual risk profiles differ significantly. The controversy highlights broader tensions within public health between centralized guidance designed to maximize collective protection and emerging calls for more personalized approaches to care, with the ACIP’s recommendation serving as a flashpoint in ongoing debates over the balance between individual choice and population-level health strategies.
GOP Embraces Psychedelics President Donald Trump has directed federal agencies to accelerate research into psychedelic substances such as LSD, MDMA, peyote, and ibogaine for potential therapeutic use, marking a significant shift from decades of Republican opposition rooted in the strict anti-drug policies established during the Nixon administration. Conservative resistance to psychedelics has softened in recent years due to a combination of emerging scientific research suggesting benefits for conditions like post-traumatic stress disorder, depression, and substance abuse, along with growing public acceptance and endorsements from high-profile figures. A major turning point has been the advocacy of military veterans, many of whom have traveled abroad for psychedelic treatments and reported substantial improvements in mental health, helping reframe these substances as medical tools rather than counterculture drugs. Influential advocates, including former Texas Governor Rick Perry and Representative Morgan Luttrell, have publicly supported expanded access after personal experiences or exposure to veteran recovery stories, contributing to bipartisan efforts in Congress to ease research restrictions. Political dynamics have also played a role, with figures like Joe Rogan reportedly encouraging policy movement and helping bring the issue into mainstream conservative discourse. At the same time, critics have raised concerns about the commercialization of psychedelic treatments, the risk of oversimplifying their effects as “miracle cures,” and the lack of emphasis on the extensive therapeutic support typically required alongside their use. The shift reflects a broader reevaluation of drug policy, driven by the opioid crisis, ongoing mental health challenges, and growing skepticism of past approaches to drug prohibition.
Autism Coordinating Committee Charts Autism rates in children are presented as rising dramatically over multiple decades, with charts showing a shift from extremely low prevalence levels in earlier periods to significantly higher rates in recent years, alongside comparisons that highlight differences by geography, gender, and time period, and the data is positioned within a broader discussion of increasing neurodevelopmental disorders and childhood chronic conditions. The content connects these trends to the work of the Interagency Autism Coordinating Committee, which operates within the U.S. Department of Health and Human Services to coordinate autism-related research and policy efforts across federal agencies, and emphasizes that the committee plays a central role in shaping national understanding, research priorities, and strategic responses to autism. The charts are framed as part of a wider effort aligned with the Make America Healthy Again initiative, which focuses on identifying potential contributing factors to rising childhood chronic disease, including environmental, dietary, medical, and societal influences, and the presentation of autism data is integrated with similar trend data for other conditions such as ADHD and developmental disorders. The material highlights the importance of coordinated federal research efforts, standardized data collection, and cross-agency collaboration to better understand prevalence patterns, underlying causes, and potential prevention or treatment strategies, while also underscoring the role of newly appointed committee members in advancing what is described as updated, “gold-standard” scientific approaches to autism research and policy development.
Children bypass age checks Children in the UK are bypassing online age verification systems by using simple tactics such as entering false birthdates and even drawing fake facial hair to trick identity checks, with research indicating that more than a third of children have successfully gotten around these safeguards intended to restrict access to age-limited content. The findings come from a study of 1,000 children conducted by Internet Matters, which showed that 32 percent admitted to bypassing age checks while 46 percent believed the systems are easy to evade, and nearly half reported encountering harmful content online despite the protections. The Online Safety Act requires platforms such as social media and pornographic websites to verify user ages, typically enforcing minimum thresholds like 13 for social media and 18 for adult content, but the report suggests these measures are often ineffective in practice. Parents are also playing a role, with one in six acknowledging they have helped their children circumvent age restrictions, while some described observing their children using creative methods like drawing moustaches to pass facial recognition checks. The research also found that around half of children had recently been asked to verify their age online, indicating that enforcement mechanisms are being deployed more widely. Despite some progress noted in shaping safer online environments, the report concludes that current verification systems remain weak and calls for stronger enforcement, greater accountability for technology companies, and potential expansion of restrictions, as the UK government considers additional measures including tighter limits or even broader social media controls for younger users.
Question of The Day!
Hello Robert,
I am asking for a homeopathy contact for my mother in Brownsville, TX. She’s 95 yrs old. Has a bladder infection. She reacted very badly to an antibiotic. Of course there is more information to consider. Any help for her at this age? She’s very weak.
Debbie
Remember Friends, The Power to Heal is Yours!
